Checking the European patent register, Afon acquired the technology last year out of bankruptcy from something called Orsus Medical, which seems to have been working on it for a while. Orsus is now defunct.
More detail:
https://www.southwalesargus.co.uk/n...-medical-research-firm-bought-administration/
A start-up business that is aiming to revolutionise the way that diabetes is monitored and managed is seeking a buyer after entering administration.
www.med-technews.com
Despite claims to be "patented", there doesn't seem to have been a patent granted yet. The patent prosecution was interrupted by the Orsus bankruptcy.
They make repeated claims like:
... recent clinical trials carried out by Afon Technology at a world leading clinical trial facility in Germany have yielded exciting results. The ability of the Afon technology device to detect changes in blood glucose compared favourably with a market leading minimally invasive blood glucose monitor.
But as far as I can see they don't include any details of the trial, which is a pretty bad look. And I don't see anything at
www.clinicaltrials.gov, which you would normally expect to have a listing if there had been a genuine "clinical trial". I guess there's a faint chance it was sponsored by some entity other than Orsus or Afon ....